Published in J Oncol on February 03, 2013
Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Breast Cancer Res Treat (2015) 0.95
Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective. Adv Nutr (2015) 0.93
Overall and central adiposity and breast cancer risk in the sister study. Cancer (2015) 0.90
Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.90
Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.87
Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications. Onco Targets Ther (2014) 0.80
Hormonal therapy and risk of breast cancer in mexican women. PLoS One (2013) 0.79
The Effect of Change in Body Mass Index on Volumetric Measures of Mammographic Density. Cancer Epidemiol Biomarkers Prev (2015) 0.79
Obesity is a significant risk factor for breast cancer in Arab women. BMC Cancer (2014) 0.78
Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women-a case-control study. J Physiol Anthropol (2016) 0.75
Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women. Int J Obes (Lond) (2015) 0.75
BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis. J Epidemiol (2016) 0.75
Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients. Front Physiol (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev (2007) 16.67
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst (2002) 9.65
The epidemiology of obesity. Gastroenterology (2007) 8.35
Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev (2002) 6.46
Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol (2008) 5.05
Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev (1993) 4.87
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev (2010) 3.75
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol (2010) 3.75
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol (2000) 2.93
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst (2011) 2.84
Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr (2009) 2.80
Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol (2008) 2.73
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41
Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem (2008) 2.40
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Selection of anthropometric indicators for classification of abdominal fatness--a critical review. Int J Obes Relat Metab Disord (1998) 2.17
Central obesity and breast cancer risk: a systematic review. Obes Rev (2003) 2.16
A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.97
Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis. Int J Cancer (2009) 1.88
Serum insulin-like growth factor-I and breast cancer. Int J Cancer (2000) 1.82
Obesity and risk of cancer in Japan. Int J Cancer (2005) 1.79
Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res (2005) 1.77
A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev (2007) 1.77
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev (2000) 1.69
Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res (2008) 1.59
Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol (2000) 1.58
Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56
The Warburg effect in 2012. Curr Opin Oncol (2012) 1.54
Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol (1999) 1.53
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res (2006) 1.50
Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer (2004) 1.46
Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab (2005) 1.41
A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer (2002) 1.38
The impact of body build on the relationship between body mass index and percent body fat. Int J Obes Relat Metab Disord (1999) 1.35
Oestrogen exposure and breast cancer risk. Breast Cancer Res (2003) 1.34
A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev (2010) 1.34
Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol (2010) 1.29
Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Curr Opin Genet Dev (2010) 1.26
Case-control study of anthropometric measures and breast cancer risk. Int J Cancer (2002) 1.23
Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. Ann Epidemiol (2002) 1.23
Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res (2002) 1.18
BMI, fat and muscle differences in urban women of five ethnicities from two countries. Int J Obes (Lond) (2007) 1.16
Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res (2004) 1.15
Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer (2007) 1.15
Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study. Am J Epidemiol (1998) 1.14
Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes (Lond) (2006) 1.13
Anthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case-control study. Br J Cancer (2008) 1.11
A review of body size and breast cancer risk in Hispanic and African American women. Cancer (2011) 1.09
Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol (2003) 1.08
Breast cancer mortality in Mexico: an age-period-cohort analysis. Salud Publica Mex (2009) 1.08
Differences in the relationship between BMI and percentage body fat between Japanese and Australian-Caucasian young men. Br J Nutr (2006) 1.07
Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol (2006) 1.05
Breast cancer and childhood anthropometry: emerging hypotheses? Breast Cancer Res (2005) 1.05
Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer (2010) 1.03
Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Res Treat (2011) 1.01
Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst (2010) 0.99
Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol (2010) 0.98
Joint effects of body size, energy intake, and physical activity on breast cancer risk. Breast Cancer Res Treat (2008) 0.97
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer (2004) 0.96
Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer (1997) 0.93
Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast (2009) 0.93
Early-life factors and breast cancer risk in Hispanic women: the role of adolescent body size. Cancer Epidemiol Biomarkers Prev (2011) 0.93
Population-based breast (female) and cervix cancer rates in the Gambia: evidence of ethnicity-related variations. Int J Cancer (2010) 0.92
Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer (2011) 0.90
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"? Int J Breast Cancer (2011) 0.89
Ethnic differences in the relationship between body mass index and percentage body fat among Asian children from different backgrounds. Br J Nutr (2011) 0.87
Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol (2005) 0.87
Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg (2005) 0.84
[Equity in access to treatment for breast cancer in Colombia]. Salud Publica Mex (2009) 0.82
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat (2002) 12.39
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene (2002) 7.04
TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol (2010) 4.92
International study of temperature, heat and urban mortality: the 'ISOTHURM' project. Int J Epidemiol (2008) 4.13
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res (2006) 4.00
An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A (2005) 3.43
The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol (2013) 3.23
De novo rates and selection of large copy number variation. Genome Res (2010) 3.08
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res (2007) 2.88
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res (2006) 2.76
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur Heart J (2011) 2.42
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett (2006) 2.37
DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene (2002) 2.27
Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in mexican children. PLoS Genet (2009) 2.27
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res (2005) 2.24
Genetics of lung-cancer susceptibility. Lancet Oncol (2010) 2.24
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ (2004) 2.23
Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study. Am J Clin Nutr (2013) 2.20
Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med (2007) 2.18
Air pollution and risk of lung cancer in a prospective study in Europe. Int J Cancer (2006) 2.17
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain. Cancer Cell (2009) 2.09
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res (2003) 2.08
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein. Hum Mutat (2002) 1.99
Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr (2012) 1.98
Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology (2011) 1.94
Air pollution, airway inflammation, and lung function in a cohort study of Mexico City schoolchildren. Environ Health Perspect (2008) 1.92
On the origin of G --> T transversions in lung cancer. Mutat Res (2003) 1.89
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res (2010) 1.89
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J Clin Invest (2010) 1.88
Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol (2011) 1.85
Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest (2005) 1.84
Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. Am J Clin Nutr (2013) 1.84
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol (2009) 1.82
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med (2013) 1.79
Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology (2014) 1.75
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol (2012) 1.70
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
From good intentions to proven interventions: effectiveness of actions to reduce the health impacts of air pollution. Environ Health Perspect (2010) 1.69
Ancestral components of admixed genomes in a Mexican cohort. PLoS Genet (2011) 1.67
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med (2012) 1.67
Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr (2012) 1.66
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy. J Clin Oncol (2013) 1.66
Toward a roadmap in global biobanking for health. Eur J Hum Genet (2012) 1.65
Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett (2011) 1.62
Traffic-related exposures, airway function, inflammation, and respiratory symptoms in children. Am J Respir Crit Care Med (2007) 1.61
Air pollution and heart rate variability among the elderly in Mexico City. Epidemiology (2003) 1.57
Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr (2011) 1.56
Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans. J Allergy Clin Immunol (2012) 1.54
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene (2005) 1.49
Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr (2011) 1.48
Biospecimen reporting for improved study quality (BRISQ). J Proteome Res (2011) 1.48
Massively regulated genes: the example of TP53. J Pathol (2010) 1.46
Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr (2009) 1.45
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch (2010) 1.44
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett (2008) 1.44
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology (2009) 1.43
Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Cancer Res (2007) 1.41
Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol (2013) 1.40
International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev (2010) 1.38
European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev (2010) 1.37
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer (2011) 1.36
Country of birth as a risk factor for asthma among Mexican Americans. Am J Respir Crit Care Med (2004) 1.35
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet (2011) 1.34
G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. Carcinogenesis (2010) 1.34
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
Gene by environment interaction in asthma. Annu Rev Public Health (2009) 1.32
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum Mutat (2010) 1.32
Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am J Respir Crit Care Med (2003) 1.28
Dietary calcium supplements to lower blood lead levels in lactating women: a randomized placebo-controlled trial. Epidemiology (2003) 1.28
Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res (2007) 1.27
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol (2010) 1.26
Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res (2004) 1.25
Joint testing of genotype and ancestry association in admixed families. Genet Epidemiol (2010) 1.25
Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep (2006) 1.24
Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer (2012) 1.23
Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. J Allergy Clin Immunol (2009) 1.23
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res (Phila) (2011) 1.23
Fruit and vegetable consumption and mortality: European prospective investigation into cancer and nutrition. Am J Epidemiol (2013) 1.22
Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett (2009) 1.22
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol Biomarkers Prev (2011) 1.21
Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer (2004) 1.21
The reliability of the Minimum European Health Module. Int J Public Health (2009) 1.21